Literature DB >> 32392302

AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations.

Zhen Wah Tan1, Enrico Guarnera1, Wei-Ven Tee1,2, Igor N Berezovsky1,2.   

Abstract

The AlloSigMA 2 server provides an interactive platform for exploring the allosteric signaling caused by ligand binding and/or mutations, for analyzing the allosteric effects of mutations and for detecting potential cancer drivers and pathogenic nsSNPs. It can also be used for searching latent allosteric sites and for computationally designing allosteric effectors for these sites with required agonist/antagonist activity. The server is based on the implementation of the Structure-Based Statistical Mechanical Model of Allostery (SBSMMA), which allows one to evaluate the allosteric free energy as a result of the perturbation at per-residue resolution. The Allosteric Signaling Map (ASM) providing a comprehensive residue-by-residue allosteric control over the protein activity can be obtained for any structure of interest. The Allosteric Probing Map (APM), in turn, allows one to perform the fragment-based-like computational design experiment aimed at finding leads for potential allosteric effectors. The server can be instrumental in elucidating of allosteric mechanisms and actions of allosteric mutations, and in the efforts on design of new elements of allosteric control. The server is freely available at: http://allosigma.bii.a-star.edu.sg.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2020        PMID: 32392302      PMCID: PMC7319554          DOI: 10.1093/nar/gkaa338

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Alloscore: a method for predicting allosteric ligand-protein interactions.

Authors:  Shuai Li; Qiancheng Shen; Minyi Su; Xinyi Liu; Shaoyong Lu; Zhongjie Chen; Renxiao Wang; Jian Zhang
Journal:  Bioinformatics       Date:  2016-01-22       Impact factor: 6.937

2.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

Review 3.  'Latent drivers' expand the cancer mutational landscape.

Authors:  Ruth Nussinov; Chung-Jung Tsai
Journal:  Curr Opin Struct Biol       Date:  2015-02-05       Impact factor: 6.809

Review 4.  Advancing Drug Discovery via Artificial Intelligence.

Authors:  H C Stephen Chan; Hanbin Shan; Thamani Dahoun; Horst Vogel; Shuguang Yuan
Journal:  Trends Pharmacol Sci       Date:  2019-07-15       Impact factor: 14.819

Review 5.  Allostery in disease and in drug discovery.

Authors:  Ruth Nussinov; Chung-Jung Tsai
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 6.  Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease.

Authors:  Igor V Kurochkin; Enrico Guarnera; Igor N Berezovsky
Journal:  Trends Pharmacol Sci       Date:  2017-11-10       Impact factor: 14.819

7.  Exploring the limits of the usefulness of mutagenesis in studies of allosteric mechanisms.

Authors:  Qingling Tang; Aileen Y Alontaga; Todd Holyoak; Aron W Fenton
Journal:  Hum Mutat       Date:  2017-05-23       Impact factor: 4.878

8.  Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.

Authors:  Minghui Li; Stephen C Kales; Ke Ma; Benjamin A Shoemaker; Juan Crespo-Barreto; Andrew L Cangelosi; Stanley Lipkowitz; Anna R Panchenko
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

9.  MMDB and VAST+: tracking structural similarities between macromolecular complexes.

Authors:  Thomas Madej; Christopher J Lanczycki; Dachuan Zhang; Paul A Thiessen; Renata C Geer; Aron Marchler-Bauer; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

10.  AlloSigMA: allosteric signaling and mutation analysis server.

Authors:  Enrico Guarnera; Zhen Wah Tan; Zejun Zheng; Igor N Berezovsky
Journal:  Bioinformatics       Date:  2017-12-15       Impact factor: 6.937

View more
  14 in total

Review 1.  Allostery, and how to define and measure signal transduction.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Biophys Chem       Date:  2022-01-29       Impact factor: 2.352

Review 2.  Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Yonglan Liu; Chung-Jung Tsai; Hyunbum Jang
Journal:  J Mol Biol       Date:  2022-04-01       Impact factor: 6.151

3.  Drugging multiple same-allele driver mutations in cancer.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Hyunbum Jang
Journal:  Expert Opin Drug Discov       Date:  2021-03-26       Impact factor: 7.050

4.  Analyzing In Silico the Relationship Between the Activation of the Edema Factor and Its Interaction With Calmodulin.

Authors:  Irène Pitard; Damien Monet; Pierre L Goossens; Arnaud Blondel; Thérèse E Malliavin
Journal:  Front Mol Biosci       Date:  2020-12-04

5.  Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells.

Authors:  Qiufen Zhang; Yingyi Chen; Duan Ni; Zhimin Huang; Jiacheng Wei; Li Feng; Jun-Cheng Su; Yingqing Wei; Shaobo Ning; Xiuyan Yang; Mingzhu Zhao; Yuran Qiu; Kun Song; Zhengtian Yu; Jianrong Xu; Xinyi Li; Houwen Lin; Shaoyong Lu; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2021-07-02       Impact factor: 11.413

6.  Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators.

Authors:  Shaoyong Lu; Yingyi Chen; Jiacheng Wei; Mingzhu Zhao; Duan Ni; Xinheng He; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2020-09-19       Impact factor: 11.413

Review 7.  PI3K inhibitors: review and new strategies.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Chem Sci       Date:  2020-05-19       Impact factor: 9.825

8.  Allosteric regulation of glutamate dehydrogenase deamination activity.

Authors:  Soumen Bera; Mubasher Rashid; Alexander B Medvinsky; Gui-Quan Sun; Bai-Lian Li; Claudia Acquisti; Adnan Sljoka; Amit Chakraborty
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

Review 9.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22

10.  Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein.

Authors:  Zhen Wah Tan; Wei-Ven Tee; Firdaus Samsudin; Enrico Guarnera; Peter J Bond; Igor N Berezovsky
Journal:  Structure       Date:  2022-01-20       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.